VHIO´s Joan Seoane elected as Fellow of the prestigious European Academy of Cancer Sciences

Launched back in 2009, the European Academy of Cancer Sciences, presided by Alexander M.M. Eggermont, also Director General of Gustave Roussy Cancer Campus Grand Paris, (Villejuif, France), has just announced its annual fellowship election results. In the company of some 200 eminent and previously appointed Academy Fellows from across Europe, Joan Seoane, Director of Translational Research at VHIO, will join this ´virtual´ hub of professionals with outstanding scientific and academic backgrounds from all disciplines in oncology in order to contribute independent, authoritative and evidence-based advice to better guide policy for the prevention, management and the palliation of cancer in Europe.

More specifically, Joan will work with the Academy´s other renowned figures on joint projects to ensure that the interests of cancer patients are at the forefront of EU policy by addressing major issues including facilitating equitable access to optimal, affordable cancer care for patients across Europe.

As a Fellow of the Academy, Joan will also contribute to the preparation of position papers as well as interact with EU institutions to create proposals and drive the implementation of new policies aimed at ensuring that cancer remains at the top of the European health and research agenda.

Commenting for VHIO Communications, Joan noted, “I am truly honored to serve as Fellow of this most prestigious body and gratefully thank all those who supported my nomination. Without the many must-have conversations with EU policymakers and other key stakeholders, today´s advances in predictive cancer science, treatment and care, as well as prevention strategies, cannot possibly hope to benefit an increasing number of our patients, across borders. This Academy assumes an important role in fostering, maintaining and developing this essential interaction that will ultimately serve to spur our collective efforts aimed at delivering on the true promise of precision medicine for as many patients as possible”.

###

 

Related Posts